(Q33611926)

28 July 2017

0 references

Systematic review and guide to selection of selective serotonin reuptake inhibitors (English)

1 reference

28 July 2017

0 references

1 reference

Edwards JG

1

1 reference

28 July 2017

Anderson I

series ordinal

2

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

507-533

1 reference

28 July 2017

1 reference

12 December 2020

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression

1 reference

12 December 2020

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Effect of fluoxetine on the electrocardiogram.

1 reference

12 December 2020

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression

1 reference

12 December 2020

Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine

1 reference

12 December 2020

Acute fluvoxamine poisoning.

1 reference

12 December 2020

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.

1 reference

12 December 2020

Prescription-event monitoring: methodology and recent progress

1 reference

12 December 2020

Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

12 December 2020

Testing for adverse reactions using prescription event monitoring.

1 reference

12 December 2020

Pharmacology of antidepressants--characteristics of the ideal drug

1 reference

12 December 2020

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

12 December 2020

Fluoxetine and suicidal ideation

1 reference

12 December 2020

The safety of fluoxetine--an update

1 reference

12 December 2020

Fatal overdose with citalopram?

1 reference

12 December 2020

Spontaneous reporting of adverse drug reactions. II: Uses

1 reference

12 December 2020

Cost-effectiveness of antidepressant treatment reassessed

1 reference

12 December 2020

Direct cost saving of SSRI overdose

1 reference

12 December 2020

Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.

1 reference

12 December 2020

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

12 December 2020

A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression

1 reference

12 December 2020

Selective Serotonin Reuptake Inhibitors: Pharmacologic Profiles and Potential Therapeutic Distinctions

1 reference

12 December 2020

Comparative effects of fluoxetine and amitriptyline on cardiac function

1 reference

12 December 2020

Effects of antidepressant drugs on sexual function

1 reference

12 December 2020

A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

1 reference

12 December 2020

The Emergence of Suicidal Ideation and Behavior During Antidepressant Pharmacotherapy

1 reference

12 December 2020

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

1 reference

12 December 2020

Fluoxetine in medically stable, depressed geriatric patients: effects on weight

1 reference

12 December 2020

Effect of paroxetine on the electrocardiogram

1 reference

12 December 2020

Source of funding and outcome of clinical trials

1 reference

12 December 2020

Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring

1 reference

12 December 2020

Newer antidepressants and the cytochrome P450 system

1 reference

12 December 2020

Antidepressant discontinuation reactions

1 reference

12 December 2020

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

1 reference

12 December 2020

The safety profile of paroxetine

1 reference

12 December 2020

Prescription-event monitoring of 10,895 patients treated with alprazolam.

1 reference

12 December 2020

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

1 reference

12 December 2020

Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors

1 reference

12 December 2020

Additional cases of suicidal ideation associated with fluoxetine

1 reference

12 December 2020

Antidepressant Induced Suicidal Ideation: Creaney W, Murray I, Healy D Academic Sub-Department of Psychological Medicine, North Wales Hospital, Denbigh, Clwyd, LL16 5SS

1 reference

12 December 2020

Comparative efficacy of antidepressants

1 reference

12 December 2020

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

1 reference

12 December 2020

Prescription-event monitoring of 10,401 patients treated with fluvoxamine

1 reference

12 December 2020

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Toleration and safety of sertraline: experience worldwide

1 reference

12 December 2020

Symptoms and signs of severe citalopram overdose

1 reference

12 December 2020

Spontaneous reporting of adverse drug reactions

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance

1 reference

12 December 2020

Suicidal ideation related to fluoxetine treatment

1 reference

12 December 2020

Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects

1 reference

12 December 2020

Spontaneous reporting of adverse drug reactions. I: the data

1 reference

12 December 2020

A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.

1 reference

12 December 2020

A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

1 reference

12 December 2020

The electrocardiogram as a tool for therapeutic monitoring: a critical analysis

1 reference

12 December 2020

Guillain-Barré syndrome following zimeldine treatment

1 reference

12 December 2020

Terminology in prescription-event monitoring

1 reference

12 December 2020

Study of United Kingdom product licence applications containing new active substances, 1987-9

1 reference

12 December 2020

Pharmacologic profile and efficacy of venlafaxine.

1 reference

12 December 2020

Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization.

1 reference

12 December 2020

A comparison of fluvoxamine and fluoxetine in the treatment of major depression

1 reference

12 December 2020

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

12 December 2020

Prescriber profile and post-marketing surveillance

1 reference

12 December 2020

The side effect profile and safety of fluoxetine

1 reference

12 December 2020

Fluvoxamine. A review of its safety profile in world-wide studies.

1 reference

12 December 2020

Selective serotonin reuptake inhibitor dose titration in the naturalistic setting.

1 reference

12 December 2020

Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men

1 reference

12 December 2020

Emergence of intense suicidal preoccupation during fluoxetine treatment

1 reference

12 December 2020

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression

1 reference

12 December 2020

The SSRIs: advantages, disadvantages and differences

1 reference

12 December 2020

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Relative mortality from overdose of antidepressants

1 reference

12 December 2020

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients

1 reference

12 December 2020

Fatal overdose with citalopram.

1 reference

12 December 2020

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

1 reference

12 December 2020

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.

1 reference

12 December 2020

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

10.2165/00003495-199957040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1033743077

0 references

1 reference